Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Equillium, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 26 | 26 | 0 |
| Shares | 8.72M | 8.71M | −10.9K (−0.1%) |
| Value | $7.25M | $6.52M | −$731.7K (−10.1%) |
New holders (6)
Institutions that held Equillium, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 41,644 | $31.2K | 0.00% |
| Jane Street Group, LLC | 19,754 | $14.8K | 0.00% |
| CI Private Wealth, LLC | 11,000 | $8.23K | 0.00% |
| Morgan Stanley | 6,885 | $5.15K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,963 | $4.46K | 0.00% |
| SBI Securities Co., Ltd. | 765 | $572 | 0.00% |
Sold out (6)
Institutions that held Equillium, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| HRT Financial LP | 18,064 | $15.0K |
| GWM Advisors LLC | 17,700 | $14.7K |
| XTX Topco Ltd | 16,955 | $14.1K |
| ADAR1 Capital Management, LLC | 7,318 | $6.09K |
| Lazard Asset Management LLC | 1,594 | $1.00K |
| Barclays PLC | 104 | $87 |